Next deadline: FDA feedback on generative-AI medical devices is due Monday, Oct 19, 2026 (docket FDA-2026-N-7874). This page lists open public comment periods on health-AI policy, each linked to its primary source. Updated Oct 17, 2026.
Open
| Due | Agency | What | Docket | Source |
|---|---|---|---|---|
| Oct 19, 2026 | FDA (CDRH) | Discussion paper: Considerations for the Regulation of Generative AI-Enabled Medical Devices | FDA-2026-N-7874 | FDA |
| Nov 20, 2026 | CDC | Request for information: Data Intermediaries and Approaches To Strengthen Public Health Data Exchange (asks how AI capabilities may affect data intermediaries' roles) | CDC-2026-1519 | Federal Register 2026-19271 |
| Nov 30, 2026 | FDA (CDRH) | FY2027 guidance priorities (A and B lists), which include AI-enabled device lifecycle, PCCP and generative-AI mental health device guidances | FDA-2012-N-1021 | RAPS |
Recently closed
| Closed | Agency | What | Docket / document |
|---|---|---|---|
| Feb 27, 2026 | ASTP/ONC | HTI-5 proposed rule (would remove AI "model card" requirements); no final rule yet. Explainer | 90 FR 60970 |
How we build this list: we search the Federal Register for open HHS, FDA, CMS and CDC comment periods that mention artificial intelligence, add FDA and ONC documents announced outside the Federal Register, and check each against its primary source. Corrections: [email protected].